Clinical Trial Update: Abiraterone Post Ketoconazole for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on abiraterone after ketoconazole failure in prostate cancer; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-01-08